Related Experiment Video
Updated: May 30, 2026

12:59
Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Published on: September 26, 2013
Optimization of human Th17 cell differentiation in vitro: evaluating different polarizing factors
Mazdak Ganjalikhani Hakemi1, Kamran Ghaedi, Alireza Andalib
1Immunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
In Vitro Cellular & Developmental Biology. Animal
|August 20, 2011
Summary
Optimizing human Th17 cell differentiation requires specific cytokine combinations. Transforming growth factor-beta (TGF-β) at average concentrations positively regulates Th17 development, influencing cytokine secretion profiles.
Area of Science:
- Immunology
- Cell Biology
Background:
- Human Th17 cell differentiation protocols vary, leading to discrepancies in research findings.
- Understanding optimal conditions and the role of specific cytokines like TGF-β is crucial for reliable Th17 cell studies.
Purpose of the Study:
- To determine the optimal cytokine combination for human Th17 cell differentiation.
- To elucidate the specific role of TGF-β in this differentiation process.
Main Methods:
- Naïve CD4(+) T cells were isolated from human cord blood.
- Cells were cultured in serum-free X-VIVO 15 or RPMI 1640 with FBS.
- Cells were treated with various combinations of TGF-β, IL-1β, IL-6, IL-23, and IL-21.
- Gene and cytokine expression analyzed via real-time quantitative RT-PCR and ELISA.
Main Results:
- A combination of TGF-β, IL-6, and IL-23 in X-VIVO 15 medium yielded the best human Th17 cell differentiation.
- TGF-β acts as a positive regulator of Th17 differentiation at average concentrations.
- Absence of TGF-β led to double-secreting Th17 cells (IL-17 and IFN-γ), while its presence induced single-secreting (IL-17) cells.
Conclusions:
- X-VIVO 15 medium with TGF-β, IL-6, and IL-23 represents an optimal condition for human Th17 differentiation.
- TGF-β concentration critically influences Th17 cell polarization and cytokine production, specifically IL-17 and IFN-γ co-expression.

